MedPath

Dr. Willmar Schwabe GmbH & Co. KG

Dr. Willmar Schwabe GmbH & Co. KG logo
🇩🇪Germany
Ownership
Private
Established
1866-01-01
Employees
1K
Market Cap
-
Website
http://www.schwabe.de

Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)

Phase 3
Completed
Conditions
Common Cold
Interventions
Drug: Placebo
First Posted Date
2014-06-25
Last Posted Date
2017-01-12
Lead Sponsor
Dr. Willmar Schwabe GmbH & Co. KG
Target Recruit Count
720
Registration Number
NCT02174653
Locations
🇬🇧

Cardiff University, Common Cold Centre, Cardiff School of Biosciences, Cardiff, Wales, United Kingdom

WS®1442 in Slightly Overweight Subjects

Phase 1
Completed
Conditions
Overweight
Interventions
Behavioral: Nordic walking training 2 x 30 min/week
Behavioral: Nordic walking training 4x45 min/week
Drug: WS® 1442 900 mg/d
Drug: WS® 1442 1800 mg/d
First Posted Date
2009-09-23
Last Posted Date
2014-05-14
Lead Sponsor
Dr. Willmar Schwabe GmbH & Co. KG
Target Recruit Count
60
Registration Number
NCT00982501
Locations
🇦🇹

University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, Salzburg, Austria

© Copyright 2025. All Rights Reserved by MedPath